Medacta Group SA (MOVE) — Capital Reinvestment Ratio
Latest as of June 2025:
0.76x
Medacta Group SA (MOVE) has a Capital Reinvestment Ratio of 0.76x as of June 2025, meaning it reinvests 1% of its operating cash flow (CHF72.95 Million) in capital expenditures (CHF55.51 Million). See Medacta Group SA free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.76x
Capex / Operating Cash Flow
Operating Cash Flow
CHF72.95 Million
CHF
Capital Expenditures
CHF55.51 Million
CHF
Data as of
Jun 2025
Most recent filing
Medacta Group SA Capital Reinvestment Ratio (2016–2024)
This chart tracks Medacta Group SA's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Medacta Group SA (2016–2024)
Year-by-year Capital Reinvestment Ratio for Medacta Group SA from 2016 to 2024. For live market cap and broader valuation context, see Medacta Group SA market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CHF) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.98x | CHF107.14 Million | CHF104.69 Million | ▼ -10.7% |
| 2023 | 1.09x | CHF75.13 Million | CHF82.22 Million | ▲ +27.4% |
| 2022 | 0.86x | CHF73.51 Million | CHF63.16 Million | ▼ -0.1% |
| 2021 | 0.86x | CHF54.06 Million | CHF46.49 Million | ▲ +87.8% |
| 2020 | 0.46x | CHF59.59 Million | CHF27.29 Million | ▼ -52.9% |
| 2019 | 0.97x | CHF42.63 Million | CHF41.47 Million | ▲ +17.2% |
| 2018 | 0.83x | CHF66.41 Million | CHF55.13 Million | ▲ +6.8% |
| 2017 | 0.78x | CHF51.59 Million | CHF40.11 Million | ▲ +54.8% |
| 2016 | 0.50x | CHF56.31 Million | CHF28.29 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow